Corval is a cloud-based commercialization planning platform that helps biopharma companies transform complex strategies into actionable, adaptable plans. Replacing fragmented spreadsheets and disconnected planning tools with a single, dynamic system of record, Corval brings together multi-year commercialization roadmaps, budgets, resource plans, and scenario modeling in one collaborative environment. Enhanced with industry data and evolving AI capabilities, Corval enables teams to plan with greater confidence, align stakeholders, anticipate change, and make smarter decisions throughout the commercialization journey. Part of The NemetzGroup, Corval is available as a standalone subscription platform or alongside expert advisory services, combining powerful technology with hands-on biopharma expertise.
| Website | http://www.corval.io |
| Employees | 13 (10 on RocketReach) |
| Founded | 2018 |
| Technologies | |
| Industry | Biotechnology Research |
| Keywords | Saas, Technology, Biotechnology, Pharmaceutical, Commercialization, Cloud Computing, Planning Platform, Biopharma, Life Sciences, Healthcare, Clinical Trials, Drug Development, Software, Data Analytics, Regulatory Affairs, Market Access, Analytics Platform, Sales Forecasting, Supply Chain, Big Data |
| Competitors | Fuel50, Gloat, Workday, IBM, LinkedIn, Oracle, SAP, ADP, Lattice +42 more (view full list) |
Looking for a particular Corval employee's phone or email?
Susan Nemetz is the Founder and CEO of Corval.
10 people are employed at Corval.
Corval is based in Boston, Massachusetts.